Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale ...
Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...
Greenwich LifeSciences, Inc. provided an update on its Phase III clinical trial, FLAMINGO-01, which is investigating the immunotherapy GLSI-100 for preventing breast cancer recurrences. The Data ...
Drugs are man-made miracles. They enhance our health, cure diseases, and extend our lives. However, drug development is not easy. It is a remarkably long, expensive, and complex process. On average, ...
The trouble with FDA's move to require only one study for new drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results